Cite
Combination therapy of chitosan, gynostemma, and motherwort alleviates the progression of experimental rat chronic renal failure by inhibiting STAT1 activation
MLA
Xin Li, et al. “Combination Therapy of Chitosan, Gynostemma, and Motherwort Alleviates the Progression of Experimental Rat Chronic Renal Failure by Inhibiting STAT1 Activation.” Oncotarget, vol. 9, Jan. 2018, pp. 15498–511. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4b2ab6036da8163d16d1e97a684d5ebe&authtype=sso&custid=ns315887.
APA
Xin Li, Shanshan An, Jihua Fu, Shudong Wang, Wenbing Yao, Mengjie Guo, Shaoxin Ma, Guangming Gong, Wenya Liu, & Wenxia Bai. (2018). Combination therapy of chitosan, gynostemma, and motherwort alleviates the progression of experimental rat chronic renal failure by inhibiting STAT1 activation. Oncotarget, 9, 15498–15511.
Chicago
Xin Li, Shanshan An, Jihua Fu, Shudong Wang, Wenbing Yao, Mengjie Guo, Shaoxin Ma, Guangming Gong, Wenya Liu, and Wenxia Bai. 2018. “Combination Therapy of Chitosan, Gynostemma, and Motherwort Alleviates the Progression of Experimental Rat Chronic Renal Failure by Inhibiting STAT1 Activation.” Oncotarget 9 (January): 15498–511. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....4b2ab6036da8163d16d1e97a684d5ebe&authtype=sso&custid=ns315887.